New medicines of Novartis in China to be launched this year
Because of the 29 percent rise of China sales for its patent medicines, the Swiss drug maker Novartis shows that they may start six new medicines in the domestic market this year.
Senior company executives forecasted that there would be 30 percent growth in sales as sales rose to 3.3 billion yuan in 2008.
Jeffrey, chief executive officer, Novartis China said that 2008 is the best year in their sales in recent years, in spite of the financial turmoil.
This year, a global sales growth of five percent is Novartis’ target. According to Li, the proportion of Novartis’ global sales in China is one percent.
2.26 billion yuan has already been invested and more will be laid in establishing infrastructure, research and Read more…
Popularity: 6% [?]
